Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-a therapy.

Autores de IIS La Fe

• Joaquín Rueda Soriano

  Autor

• Carlos Gonzalez Juanatey

  Autor

Participantes ajenos a IIS La Fe

• Genre F
• López-Mejías R
• Miranda-Filloy JA
• Carnero-López B
• Gómez-Acebo I
• Blanco R
• Ochoa R
• Llorca J
• González-Gay MÁ

Grupos

• Hemostasia, Trombosis, Arteriosclerosis y Biología vascular

Abstract

To evaluate whether anti-TNF-a therapy (infliximab) administration alters circulating levels of ghrelin, an anti-inflammatory gastric peptide. We also assessed possible associations of circulating ghrelin concentrations with CRP and ESR levels, metabolic syndrome, demographic characteristics and other adipokines in ankylosing spondylitis (AS) patients.